Abstract Purpose of Review The role of the gut microbiota in modulating blood pressure is
increasingly being recognized, currently. The purpose of this review is to summarize recent …

Background: In contemporary clinical practice, there is an increasing need for new clinically
relevant biomarkers potentially optimizing management strategies in patients with suspected …

Atherosclerosis contributes to the majority of deaths related to cardiovascular disease
(CVD). Recently, the nonspecific inflammatory biomarker soluble urokinase plasminogen …

Soluble urokinase plasminogen activator receptor (suPAR) is a risk factor for kidney
diseases. In addition to suPAR, proteolysis of membrane-bound uPAR results in circulating …

Background Literature suggests a bidirectional association between advanced hepatic
fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with …

Background Despite modern antiretroviral therapy (ART), people living with HIV (PLWH)
have increased relative risk of inflammatory-driven comorbidities, including cardiovascular …

Context Obesity is a risk factor for coronavirus disease 2019 (COVID-19)-related outcomes;
however, the mechanism remains unclear. Objective The objective of this analysis was to …

Aim To evaluate the effect of four different drug classes on soluble urokinase plasminogen
activator receptor (suPAR), a biomarker active in multiple inflammatory processes and a risk …

Venous thromboembolic disease (VTE) is a prevalent and potentially life-threatening
vascular disease including both deep vein thrombosis and pulmonary embolism. This …

Abstract Purpose of Review Patients with established coronary artery disease (CAD) are at
high residual risk for adverse events, despite guideline-based treatments. Herein, we aimed …